Zurich Cantonal Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$226M Buy
1,624,637
+11,029
+0.7% +$1.54M 0.49% 24
2025
Q4
$198M Buy
1,613,608
+19,741
+1% +$2.4M 0.43% 26
2025
Q3
$177M Buy
1,593,867
+9,685
+0.6% +$1.1M 0.41% 33
2025
Q2
$176M Buy
1,584,182
+64,849
+4% +$6.9M 0.43% 34
2025
Q1
$170M Buy
1,519,333
+107,654
+8% +$11.1M 0.49% 30
2024
Q4
$130M Buy
1,411,679
+563,444
+66% +$50.7M 0.37% 34
2024
Q3
$71.1M Buy
848,235
+74,063
+10% +$5.65M 0.21% 84
2024
Q2
$53.1M Sell
774,172
-414,189
-35% -$27.6M 0.17% 99
2024
Q1
$87M Sell
1,188,361
-302,892
-20% -$23.3M 0.3% 60
2023
Q4
$121M Buy
1,491,253
+73,824
+5% +$5.74M 0.46% 33
2023
Q3
$106M Sell
1,417,429
-25,271
-2% -$1.94M 0.47% 37
2023
Q2
$111M Buy
1,442,700
+575,842
+66% +$45.9M 0.49% 34
2023
Q1
$71.9M Buy
866,858
+40,248
+5% +$3.33M 0.35% 58
2022
Q4
$71M Buy
826,610
+75,606
+10% +$5.99M 0.38% 51
2022
Q3
$46.3M Buy
751,004
+12,666
+2% +$799K 0.27% 72
2022
Q2
$45.6M Sell
738,338
-49,013
-6% -$3.03M 0.27% 76
2022
Q1
$46.8M Buy
787,351
+57,698
+8% +$3.69M 0.23% 89
2021
Q4
$53M Buy
729,653
+38,431
+6% +$2.65M 0.26% 76
2021
Q3
$48.3M Buy
691,222
+48,650
+8% +$3.42M 0.26% 81
2021
Q2
$44.2M Buy
642,572
+50,827
+9% +$3.39M 0.25% 87
2021
Q1
$38.2M Sell
591,745
-86,180
-13% -$5.56M 0.23% 92
2020
Q4
$39.5M Buy
677,925
+43,740
+7% +$2.64M 0.24% 84
2020
Q3
$40.1M Buy
634,185
+36,532
+6% +$2.53M 0.28% 74
2020
Q2
$46M Buy
597,653
+7,542
+1% +$578K 0.4% 46
2020
Q1
$44.1M Buy
590,111
+7,286
+1% +$503K 0.41% 46
2019
Q4
$37.9M Sell
582,825
-252,321
-30% -$16.4M 0.29% 65
2019
Q3
$52.9M Buy
835,146
+17,924
+2% +$1.17M 0.44% 46
2019
Q2
$55.2M Buy
817,222
+31,162
+4% +$2.05M 0.47% 39
2019
Q1
$51.1M Buy
786,060
+67,505
+9% +$4.49M 0.46% 40
2018
Q4
$44.9M Sell
718,555
-2,306
-0.3% -$161K 0.45% 40
2018
Q3
$55.7M Sell
720,861
-28,866
-4% -$2.18M 0.47% 29
2018
Q2
$53.1M Buy
749,727
+188,646
+34% +$13.3M 0.47% 30
2018
Q1
$42.3M Buy
561,081
+250,336
+81% +$19.9M 0.38% 46
2017
Q4
$22.3M Buy
310,745
+676
+0.2% +$51.3K 0.2% 113
2017
Q3
$25.1M Buy
310,069
+18,251
+6% +$1.4M 0.23% 96
2017
Q2
$20.7M Sell
291,818
-29,766
-9% -$1.98M 0.2% 113
2017
Q1
$21.8M Sell
321,584
-133,798
-29% -$9.41M 0.22% 107
2016
Q4
$32.6M Sell
455,382
-110,212
-19% -$8.19M 0.34% 65
2016
Q3
$44.8M Sell
565,594
-296
-0.1% -$24K 0.47% 41
2016
Q2
$47.2M Sell
565,890
-100,515
-15% -$8.92M 0.61% 29
2016
Q1
$61.2M Buy
666,405
+67,055
+11% +$6.05M 0.78% 20
2015
Q4
$60.6M Buy
599,350
+15,246
+3% +$1.59M 0.77% 21
2015
Q3
$57.4M Buy
584,104
+32,263
+6% +$3.58M 0.81% 14
2015
Q2
$64.6M Buy
551,841
+366
+0.1% +$40K 0.89% 12
2015
Q1
$54.1M Buy
551,475
+327,251
+146% +$33.2M 0.75% 18
2014
Q4
$21.1M Buy
224,224
+60,458
+37% +$6.25M 0.65% 24
2014
Q3
$17.4M Sell
163,766
-231,612
-59% -$22.7M 0.57% 29
2014
Q2
$32.8M Sell
395,378
-21,577
-5% -$1.68M 0.96% 11
2014
Q1
$29.5M Buy
416,955
+30,907
+8% +$2.42M 0.91% 10
2013
Q4
$29M Sell
386,048
-36,946
-9% -$2.57M 0.95% 8
2013
Q3
$26.6M Sell
422,994
-43,442
-9% -$2.6M 0.92% 8
2013
Q2
$23.9M Buy
+466,436
New +$24.3M 0.83% 11

Other funds holding GILD

Zurich Cantonal Bank's GILD Position: Q1 2026 in Review

Zurich Cantonal Bank increased its Gilead Sciences (GILD) stake by 0.68% in Q1 2026, buying an estimated $1.54M and bringing the position to 1,624,637 shares worth $226M. The position accounts for 0.49% of the portfolio, ranked #24.

Zurich Cantonal Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Zurich Cantonal Bank held 1,624,637 shares of Gilead Sciences worth $226M as of Q1 2026.
  • Zurich Cantonal Bank bought 11,029 Gilead Sciences shares in Q1 2026, an estimated $1.54M.
  • Gilead Sciences made up 0.49% of Zurich Cantonal Bank's portfolio in Q1 2026, its #24 holding.
  • Zurich Cantonal Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.